Considering a partnership
Before you commit, we help you understand the US market, evaluate potential partners and know exactly what an agreement means for you.
Before you sign →We advise pharmaceutical manufacturers and product owners who are considering a US commercial partner, or who are already in a partnership and want to understand what they signed and how it is working.
Independent advice for the company that makes or owns the product.
US commercial agreements are complex, and the partner across the table usually knows the market far better than you do. We close that gap.
Before you commit, we help you understand the US market, evaluate potential partners and know exactly what an agreement means for you.
Before you sign →
If you signed an agreement and aren't sure how it works or whether it is performing, we help you understand it and get the relationship on track.
After you sign →
Market overviews, gross-to-net projections and forecasts for approved products, pending approvals and molecules under evaluation.
Market analysis →Most conversations begin with a simple question the client hasn't been able to answer.
Our clients make or own the product. We make sure they understand the partnership that brings it to the US market.
Considering a US commercial partner for the first time.
Weighing offers from US distributors and marketers.
Already selling through a US partner and unsure how it is really working.
Preparing to renew, renegotiate or exit an existing agreement.
A harbor open to every ship, and a fair deal for every trader.
For nearly three thousand years, merchants from across the Mediterranean traded in Palermo's port. We bring that idea to the US pharmaceutical market.
Our story →